Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Safety and Feasibility Study of the RejuvenAir™ System Metered Cryospray Therapy for Chronic Bronchitis Patients

NCT02483637 is registered in ClinicalTrials.gov with CSA Medical, Inc. as lead sponsor.

NCT NCT02483637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02483637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Safety and Feasibility Study of the RejuvenAir™ System Metered Cryospray Therapy for Chronic Bronchitis Patients
Lead sponsor
CSA Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
May 20, 2022
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bronchitis, chronic, cryotherapy effect